Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women
A clinical trial study
Keywords:
Royal jelly, Conjugated estrogen (Premarin), Vaginal atrophy, Quality of life, MenopauseAbstract
Objective: This study was conducted to evaluate the therapeutic effects of vaginal royal jelly and vaginal estrogen on quality of life and vaginal atrophy in postmenopausal women.
Methods: This double-blind randomized controlled clinical trial was carried out at gynecology and obstetrics clinics of Hajar Hospital of Shahrekord University of Medi¬cal Sciences (Iran) from January 2013 to January 2014. The study was conducted on married postmenopausal women between 50 and 65 years old. Of 120 patients, 30 individuals were excluded based on the exclusion criteria, and 90 women were randomly distributed into three groups of 30 royal jelly vaginal cream 15%, vaginal Premarin, and placebo (lubricant), for three months. At the beginning and the end of the study, quality of life and vaginal cytology assay were evaluated. Data were analyzed by SPSS Version 11.
Results: Vaginal cream of royal jelly is significantly more effective than vaginal cream of Premarin and lubricant in improvement of quality of life in postmenopausal women (p<0.05). Moreover, Pap smear results showed that vaginal atrophy in vaginal Premarin group was lower than the other groups (p<0.001), and there was no significant difference between lubricant and royal jelly groups (p=0.89).
Conclusion: Administration of vaginal royal jelly was effective in quality-of-life improvement of postmenopausal women. Given to the various properties of royal jelly and its effectiveness on quality of life and vaginal atrophy in postmenopausal women, further studies are recommended for using =royal jelly in improving menopausal symptoms.
Clinical trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the IRCT code: 2014112220043n1.
Funding: Shahrekord University of Medical Sciences supported this research (project no. 1440).
References
G KP, Arounassalame B. The quality of life during and after menopause among rural women. J Clin Diagn
Res. 2013; 7(1): 135-9. doi: 10.7860/JCDR/2012/4910.2688. PMID: 23450244, PMCID: PMC3576769.
Reis FM, Pestana-Oliveira N, Leite CM, Lima FB, Brandão ML, Graeff FG, et al. Hormonal changes and
increased anxiety-like behavior in a perimenopause-animal model induced by 4-vinylcyclohexene
diepoxide (VCD) in female rats. Psychoneuroendocrinology. 2014; 49: 130-40. doi:
1016/j.psyneuen.2014.06.019. PMID: 25080405.
Tangen T, Mykletun A. Depression and anxiety through the climacteric period: an epidemiological study
(HUNT-II). J Psychosom Obstet Gynaecol. 2008; 29(2): 125-31. doi: 10.1080/01674820701733945.
PMID: 18484441.
Llaneza P, Garcia-Portilla MP, Llaneza-Suarez D, Armott B, Perez-Lopez FR. Depressive disorders and the
menopause transition. Maturitas. 2012; 71(2): 120-30. doi: 10.1016/j.maturitas.2011.11.017. PMID:
Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at
postmenopause. Climacteric. 2014; 17(1): 3-9. doi: 10.3109/13697137.2013.871696. PMID: 24423885.
Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American
Menopause Society. Menopause. 2013; 20(9): 888-902. doi: 10.1097/GME.0b013e3182a122c2. PMID:
Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women.
Cochrane Database Syst Rev. 2006(4): CD001500. doi: 10.1002/14651858.CD001500.pub2. PMID:
Pitkin J. Alternative and complementary therapies for the menopause. Menopause int. 2012; 18(1): 20-7.
doi: 10.1258/mi.2012.012001. PMID: 22393177.
Ishii R, Horie M, Murayama M, Maitani T. [Analysis of tetracyclines in honey and Royal jelly by
LC/MS/MS]. Shokuhin Eiseigaku Zasshi. 2006; 47(6): 277-83. PMID: 17228793.
Abdelatif M, Yakoot M, Etmaan M. Safety and efficacy of a new honey ointment on diabetic foot ulcers: a
prospective pilot study. J Wound Care. 2008; 17(3): 108-10. doi: 10.12968/jowc.2008.17.3.28667. PMID:
Melliou E, Chinou I. Chemistry and bioactivity of Royal jelly from Greece. J Agric Food Chem. 2005;
(23): 8987-92. doi: 10.1021/jf051550p. PMID: 16277392.
Ghazanfarpour M, Kaviani M, Rezaiee M, Ghaderi E, Zandvakili F. Cross cultural adaptation of the
menopause specific questionnaire into the persian language. Ann Med Health Sci Res. 2014; 4(3): 325-9.
doi: 10.4103/2141-9248.133453. PMID: 24971202, PMCID: PMC4071727.
Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. American family physician.
; 61(10): 3090-6.
Pourmoradian S, Mahdavi R, Mobasseri M, Faramarzi E, Mobasseri M. Effects of Royal jelly
supplementation on glycemic control and oxidative stress factors in type 2 diabetic female: a randomized
clinical trial. Chin J Integr Med. 2014; 20(5): 347-52. doi: 10.1007/s11655-014-1804-8. PMID: 24610413.
Avis NE, Brockwell S, Randolph JF Jr, Shen S, Cain VS, Ory M, et al. Longitudinal changes in sexual
functioning as women transition through menopause: results from the Study of Women's Health Across the
Nation. Menopause. 2009; 16(3): 442-52. doi: 10.1097/gme.0b013e3181948dd0. PMID: 19212271,
PMCID: PMC2908487.
Mishima S, Suzuki KM, Isohama Y, Kuratsu N, Araki Y, Inoue M, et al. Royal jelly has estrogenic effects
in vitro and in vivo. J Ethnopharmacol. 2005; 101(1-3): 215-20. doi: 10.1016/j.jep.2005.04.012. PMID:
Narita Y, Nomura J, Ohta S, Inoh Y, Suzuki KM, Araki Y, et al. Royal jelly stimulates bone formation:
physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Biochem. 2006; 70(10):
-14. doi: 10.1271/bbb.60240. PMID: 17031045.
Okic-Djordjevic I, Trivanovic D, Krstic J, Jaukovic A, Mojsilovic S, Santibanez JF, et al. GE132+Natural:
Novel promising dietetic supplement with antiproliferative influence on prostate, colon, and breast cancer
cells. J BUON. 2013; 18(2): 504-10. PMID: 23818369.
Cumming GP, Herald J, Moncur R, Currie H, Lee AJ. Women's attitudes to hormone replacement therapy,
alternative therapy and sexual health: a web-based survey. Menopause Int. 2007; 13(2): 79-83. PMID:
Cumming GP, Currie HD, Moncur R, Lee AJ. Web-based survey on the effect of menopause on women's
libido in a computer-literate population. Menopause Int. 2009; 15(1): 8-12. doi: 10.1258/mi.2009.009001.
PMID: 19237616.
Mishima S, Suzuki KM, Isohama Y, Kuratsu N, Araki Y, Inoue M, et al. Royal jelly has estrogenic effects
in vitro and in vivo. J Ethnopharmacol. 2005; 101(1-3): 215-20. doi: 10.1016/j.jep.2005.04.012. PMID:
Narita Y, Nomura J, Ohta S, Inoh Y, Suzuki KM, Araki Y, et al. Royal jelly stimulates bone formation:
physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Biochem. 2006; 70(10):
-14. doi: 10.1271/bbb.60240. PMID: 17031045.
Okic-Djordjevic I, Trivanovic D, Krstic J, Jaukovic A, Mojsilovic S, Santibanez JF, et al. GE132+Natural:
Novel promising dietetic supplement with antiproliferative influence on prostate, colon, and breast cancer
cells. J BUON. 2013; 18(2): 504-10. doi: 10.1016/j.jep.2005.04.012. PMID: 23818369.
Nakaya M, Onda H, Sasaki K, Yukiyoshi A, Tachibana H, Yamada K. Effect of Royal jelly on bisphenol
A-induced proliferation of human breast cancer cells. Biosci Biotechnol Biochem. 2007; 71(1): 253-5. doi:
1271/bbb.60453. PMID: 17213647.
Cavusoglu K, Yapar K, Yalcin E. Royal jelly (honey bee) is a potential antioxidant against cadmiuminduced genotoxicity and oxidative stress in albino mice. J Med Food. 2009; 12(6): 1286-92. doi:
1089/jmf.2008.0203. PMID: 20041783.
Sharife N, Hasanzadeh MM, Ayate S, Shakeri M, Goroneh Z. Evaluation of expression estrogen receptor
and progesterone receptor and p53 in patients with stress urinary incontinence and pelvic organ prolapse.
JBUMS. 2012; 14(1(64)): 25-30.
Koc AN, Silici S, Kasap F, Hormet-Oz HT, Mavus-Buldu H, Ercal BD. Antifungal activity of the honeybee
products against Candida spp. and Trichosporon spp. J Med Food. 2011; 14(1-2): 128-34. doi:
1089/jmf.2009.0296. PMID: 21128826.
Raghunandan C, Agrawal S, Dubey P, Choudhury M, Jain A. A comparative study of the effects of local
estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal
women. J Sex Med. 2010; 7(3): 1284-90. doi: 10.1111/j.1743-6109.2009.01667.x. PMID: 20102444.
Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai EM. A randomized comparative study of the effects
of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized
postmenopausal women. Menopause. 2006; 13(5): 737-43. doi: 10.1097/01.gme.0000227401.98933.0b.
PMID: 16946685.
Raymundo N, Yu-cheng B, Zi-yan H, Lai CH, Leung K, Subramaniam R, et al. Treatment of atrophic
vaginitis with topical conjugated equine estrogens in postmenopausal Asian women. Climacteric. 2004;
(3): 312-8. PMID: 15669556.
Al-Baghdadi O, Ewies AA. Topical estrogen therapy in the management of postmenopausal vaginal
atrophy: an up-to-date overview. Climacteric. 2009; 12(2): 91-105. doi: 10.1080/13697130802585576.
PMID: 19117185.
Ko Y, Lin SJ, Salmon JW, Bron MS. The impact of urinary incontinence on quality of life of the elderly.
Am J Manag Care. 2005; 11(4 Suppl): S103-11. PMID: 16161383.
Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder,
incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and
emotional well-being in men and women: results from the EPIC study. BJU Int. 2008; 101(11): 1388-95.
doi: 10.1111/j.1464-410X.2008.07601.x. PMID: 18454794.
Koundi KL, Christodoulakos GE, Lambrinoudaki IV, Zervas IM, Spyropoulou A, Fexi P, et al. Quality of
life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.
Gynecol Endocrinol. 2006; 22(12): 660-8. doi: 10.1080/09513590601010557. PMID: 17162707.
Morita H, Ikeda T, Kajita K, Fujioka K, Mori I, Okada H, et al. Effect of Royal jelly ingestion for six
months on healthy volunteers. Nutr J. 2012; 11: 77. doi: 10.1186/1475-2891-11-77.
Seyyedi F, Rafiean M, Miraj S. Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on
Quality of Life, Sexual and Urinary Function in Postmenopausal Women. J Clin Diag Res. 2016; 10(5).
doi: 10.7860/jcdr/2016/17844.7715.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
